Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-004175)

Filing Details

Accession Number:: 0001209191-15-004175
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-01-14 16:03:34
Reporting Period:: 2015-01-12

Filing Date:: 2015-01-14
Accepted Time:: 2015-01-14 16:03:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1503802	Karyopharm Therapeutics Inc.	KPTI	Pharmaceutical Preparations (2834)	263931704

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1364719	Michael Kauffman	C/O Karyopharm Therapeutics Inc. 85 Wells Avenue Newton MA 02459	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-12-01	20,000	$0.00	788,963	No	5	G	Indirect	By Spouse
Common Stock	Disposition	2015-01-12	25,000	$33.00	562,596	No	4	S	Direct
Common Stock	Disposition	2015-01-12	25,000	$33.00	763,963	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By Spouse
No	4	S	Direct
No	4	S	Indirect	By Spouse

Footnotes

The sale reported on this Form 4 was effected as part of an underwritten public offering of common stock of Karyopharm Therapeutics Inc. with the Reporting Person as a selling stockholder in the offering.
The sale reported on this Form 4 was effected as part of an underwritten public offering of common stock of Karyopharm Therapeutics Inc. with the spouse of the Reporting Person as a selling stockholder in the offering.